Spinal muscular atrophy: the RNP connection

被引:91
作者
Eggert, C [1 ]
Chari, A [1 ]
Laggerbauer, B [1 ]
Fischer, U [1 ]
机构
[1] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany
关键词
D O I
10.1016/j.molmed.2006.01.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Degenerated motor neurons in the spinal cord are the pathological hallmark of spinal muscular atrophy (SMA). SMA is caused by mutations in the ubiquitously expressed survival motor neuron 1 (SMN1) gene, which lead to reduced levels of functional SMN protein. Many different functions have been assigned to SMN, including assembly of ribonucleoproteins (RNPs), splicing, transcription and axonal mRNA transport. Recently, tissue from SMA patients and animal models has been used to determine which function of SMN is affected in SMA patients. A surprising picture has emerged: the impaired assembly of RNP subunits of the spliceosome seems to be responsible for SMA pathogenesis. Here, we present a model of how this defect might cause motor-neuron degeneration and consider potential therapies.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 93 条
[1]   Phenylbutyrate increases SMN expression in vitro:: relevance for treatment of spinal muscular atrophy [J].
Andreassi, C ;
Angelozzi, C ;
Tiziano, FD ;
Vitali, T ;
De Vincenzi, E ;
Boninsegna, A ;
Villanova, M ;
Bertini, E ;
Pini, A ;
Neri, G ;
Brahe, C .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (01) :59-65
[2]   Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients [J].
Andreassi, C ;
Jarecki, J ;
Zhou, JH ;
Coovert, DD ;
Monani, UR ;
Chen, XC ;
Whitney, M ;
Pollok, B ;
Zhang, ML ;
Androphy, E ;
Burghes, AHM .
HUMAN MOLECULAR GENETICS, 2001, 10 (24) :2841-2849
[3]   Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy [J].
Azzouz, M ;
Le, T ;
Ralph, GS ;
Walmsley, L ;
Monani, UR ;
Lee, DCP ;
Wilkes, F ;
Mitrophanous, KA ;
Kingsman, SM ;
Burghes, AHM ;
Mazarakis, ND .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1726-1731
[4]   Interferons and IRF-1 induce expression of the survival motor neuron (SMN) genes [J].
Baron-Delage, S ;
Abadie, A ;
Echaniz-Laguna, A ;
Melki, J ;
Beretta, L .
MOLECULAR MEDICINE, 2000, 6 (11) :957-968
[5]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[6]   Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients [J].
Brahe, C ;
Vitali, T ;
Tiziano, FD ;
Angelozzi, C ;
Pinto, AM ;
Borgo, F ;
Moscato, U ;
Bertini, E ;
Mercuri, E ;
Neri, G .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2005, 13 (02) :256-259
[7]   Spinal muscular atrophies: Recent insights and impact on molecular diagnosis [J].
Brahe, C ;
Bertini, E .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1996, 74 (10) :555-562
[8]   Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy [J].
Brichta, L ;
Hofmann, Y ;
Hahnen, E ;
Siebzehnrubl, FA ;
Raschke, H ;
Blumcke, I ;
Eyupoglu, IY ;
Wirth, B .
HUMAN MOLECULAR GENETICS, 2003, 12 (19) :2481-2489
[9]   Is spinal muscular atrophy the result of defects in motor neuron processes? [J].
Briese, M ;
Esmaeili, B ;
Sattelle, DB .
BIOESSAYS, 2005, 27 (09) :946-957
[10]   Motor unit number estimation in infants and children with spinal muscular atrophy [J].
Bromberg, MB ;
Swoboda, KJ .
MUSCLE & NERVE, 2002, 25 (03) :445-447